Kalpataru Multiplier Ltd.

go to old website Online Payment MF portfolio login smart way to invest in gold
Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE383.600.8 (+0.21 %)
PREV CLOSE () 382.80
OPEN PRICE () 380.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 383.60 (837)
VOLUME 191147
TODAY'S LOW / HIGH ()377.75 385.00
52 WK LOW / HIGH ()350.4 678.8
NSE383.450.65 (+0.17 %)
PREV CLOSE() 382.80
OPEN PRICE () 381.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 383.45 (359)
VOLUME 3702836
TODAY'S LOW / HIGH() 377.50 385.40
52 WK LOW / HIGH ()344.55 679.3
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
24Jun BHEL, Dr. Reddy's Lab and MBL Infrastr
Bharat Heavy Electricals (BHEL) has won an order for emission control eq..
22Jun Sun Pharmaceutical Industries receives
Sun Pharmaceutical Industries has received four observations from United..
22Jun Shanghvi Finance submits disclosure
The Exchange has received the disclosure under Regulation 31(1) and 31(2..
20Jun Pharma stocks trade higher with indust
Pharma stocks were trading higher as Indian Pharmaceutical Alliance (IPA..
14Jun Sun Pharma reports interim results fro
Sun Pharmaceutical Industries has reported interim results from a Phase..
Financials
in Millions
QTR Mar 19 ANNUAL 19
Net Profit10680.68166
Gross Profit 9861.8 7194.5
Operating Profit 12377.330277
Net Sales 25521.3103032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 5428.70 (2.06%)
M.Cap ( in Cr)
12502.63
Hester Biosciences (BSE)
 1769.05 (3.75%)
M.Cap ( in Cr)
1504.91
Piramal Enterprises (BSE)
 1945.60 (2.96%)
M.Cap ( in Cr)
38687.59
Astrazeneca Pharma I (BSE)
 1942.35 (2.66%)
M.Cap ( in Cr)
4855.88
Abbott India (BSE)
 8537.20 (0.41%)
M.Cap ( in Cr)
18140.95
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.76%
MUTUAL FUNDS/UTI 9.31%
FI/BANKS/INSURANCE 7.8%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORSKYC IPO

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Devine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Investment Advisor and D.P. of this region.

Call Us 0755-2530536
Email Uskml01@kalpatarumulti.com dp@kalpatarumulti.com kalpatarubhopal@gmail.com

registration nos:

Kalparatu Multiplier Ltd.: Bombay Stock Exchange Ltd. (BSE): SEBI Regn. No. INB011115236, MEMBER ID : 3016, National Stock Exchange Ltd. (NSE) SEBI Regn. No. INB-231115230, MEMBER ID : 11152, Multi Commodity Exchange (MCX): FMC Regn. No. MCX/TCM/PROP/0834,

National Commodities Exchange of India (NCDEX): FMC Regn. No. NCDEX/TCM/PROP/0896, MEMBER ID : 00921 INZ000045136

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX39122.96-71.53 (-0.18%)
NIFTY11699.65-24.45 (-0.21%)
Dow Jones 26719.13-34.04 (-0.13%)
Nasdaq 8031.71-19.63 (-0.24%)